<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NVS</title>
    <link />
    <description>Headlines for Novartis</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Positive Data on Novartis' Jakavi  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101843/positive-data-on-novartis-jakavi.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 18 Jun 2013 21:55:01 GMT</pubDate>
    </item>
    <item>
      <title>Positive Data on Incyte's Jakafi - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101831/positive-data-on-incytes-jakafi.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 18 Jun 2013 21:00:01 GMT</pubDate>
    </item>
    <item>
      <title>This Blockbuster Biologic May Face a Steep Cliff</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/18/this-megablockbuster-biologic-may-face-a-steep-cli/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 18 Jun 2013 10:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Good News for InterMune - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101706/good-news-for-intermune.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Jun 2013 20:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1506582-amarantus-teams-with-becton-dickinson-for-lympro-development-seeking-pd-lid-candidate.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 17:16:55 GMT</pubDate>
    </item>
    <item>
      <title>3 Humongous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/15/3-humongous-health-care-stocks-this-week/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 15 Jun 2013 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging Data on Novartis' Gilenya  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101620/encouraging-data-on-novartis-gilenya.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 14 Jun 2013 21:25:01 GMT</pubDate>
    </item>
    <item>
      <title>1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/14/1-thing-you-always-wanted-to-know-about-drugs-bu-2/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Jun 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>These 2 Healthcare Stocks Could Win Big With FDA's New 'Breakthrough' Status</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1503062-these-2-healthcare-stocks-could-win-big-with-fda-s-new-breakthrough-status.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 16:02:31 GMT</pubDate>
    </item>
    <item>
      <title>Big Pharma's Biggest Opportunity</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/14/big-pharmas-biggest-opportunity/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Jun 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/these-2-health-care-stocks-could-win-big-with-fdas-new-breakthrough-status-cm253230.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 14 Jun 2013 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Novartis: Financial Projection And Stock Valuation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1502292-novartis-financial-projection-and-stock-valuation.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 10:09:03 GMT</pubDate>
    </item>
    <item>
      <title>Medivir recruits New Head of Commercial Operations</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130614-000291&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 14 Jun 2013 02:57:00 GMT</pubDate>
    </item>
    <item>
      <title>PDL BioPharma Guides Higher 2Q Royalties - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101485/pdl-biopharma-guides-higher-2q-royalties.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 13 Jun 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Novartis: Drug Pipeline And New Drug Applications</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1500902-novartis-drug-pipeline-and-new-drug-applications.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 13 Jun 2013 16:35:56 GMT</pubDate>
    </item>
    <item>
      <title>Why the Pfizer-Teva Settlement Affects the Whole Industy</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/13/why-the-pfizer-teva-settlement-affects-the-whole-i/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 13 Jun 2013 13:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Novartis: 5 Year Revenue Outlook</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1499052-novartis-5-year-revenue-outlook.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 13 Jun 2013 05:34:41 GMT</pubDate>
    </item>
    <item>
      <title>Questcor Pop: Acquisition Trumps Competition</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/12/questcor-pop-acquisition-trumps-competition/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 12 Jun 2013 20:52:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanuwave: DermaPACE Could Be Very Competitive In $2B Diabetic Foot Ulcer Market</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1497872-sanuwave-dermapace-could-be-very-competitive-in-2b-diabetic-foot-ulcer-market.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 12 Jun 2013 15:56:32 GMT</pubDate>
    </item>
    <item>
      <title>3 Drug Manufacturers With Encouraging Receivables</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1497632-3-drug-manufacturers-with-encouraging-receivables.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 12 Jun 2013 14:47:20 GMT</pubDate>
    </item>
  </channel>
</rss>
